• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重的造血干细胞炎症会损害慢性肉芽肿病的基因治疗。

Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapy.

机构信息

Human Lymphohematopoiesis Laboratory, Université Paris Cité, Imagine Institute, INSERM UMR 1163, Paris, France.

Biotherapy Department, Necker-Enfants Malades Hospital, AP-HP, Paris, France; Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, AP-HP, INSERM, Paris, France.

出版信息

Cell Rep Med. 2023 Feb 21;4(2):100919. doi: 10.1016/j.xcrm.2023.100919. Epub 2023 Jan 26.

DOI:10.1016/j.xcrm.2023.100919
PMID:36706754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9975109/
Abstract

X-linked chronic granulomatous disease (CGD) is associated with defective phagocytosis, life-threatening infections, and inflammatory complications. We performed a clinical trial of lentivirus-based gene therapy in four patients (NCT02757911). Two patients show stable engraftment and clinical benefits, whereas the other two have progressively lost gene-corrected cells. Single-cell transcriptomic analysis reveals a significantly lower frequency of hematopoietic stem cells (HSCs) in CGD patients, especially in the two patients with defective engraftment. These two present a profound change in HSC status, a high interferon score, and elevated myeloid progenitor frequency. We use elastic-net logistic regression to identify a set of 51 interferon genes and transcription factors that predict the failure of HSC engraftment. In one patient, an aberrant HSC state with elevated CEBPβ expression drives HSC exhaustion, as demonstrated by low repopulation in a xenotransplantation model. Targeted treatments to protect HSCs, coupled to targeted gene expression screening, might improve clinical outcomes in CGD.

摘要

X 连锁慢性肉芽肿病(CGD)与吞噬作用缺陷、危及生命的感染和炎症并发症有关。我们在四名患者中进行了基于慢病毒的基因治疗临床试验(NCT02757911)。两名患者表现出稳定的嵌合和临床获益,而另外两名患者则逐渐失去了基因校正细胞。单细胞转录组分析显示 CGD 患者的造血干细胞(HSCs)频率明显较低,尤其是在两名嵌合不良的患者中。这两名患者的 HSC 状态发生了深刻变化,干扰素评分高,髓样祖细胞频率升高。我们使用弹性网络逻辑回归来鉴定一组 51 个干扰素基因和转录因子,这些基因和转录因子可预测 HSC 嵌合的失败。在一名患者中,异常的 HSC 状态伴随着 CEBPβ表达的升高,导致 HSC 衰竭,异种移植模型中的低再殖证明了这一点。针对 HSC 的保护治疗,加上针对基因表达的靶向筛选,可能会改善 CGD 的临床结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/9975109/16317185df80/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/9975109/cb0f7bf3eed7/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/9975109/4cb92f36d191/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/9975109/1573ec47c51e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/9975109/d96a63a22649/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/9975109/2a8351743ff2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/9975109/dbe99eef47e4/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/9975109/16317185df80/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/9975109/cb0f7bf3eed7/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/9975109/4cb92f36d191/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/9975109/1573ec47c51e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/9975109/d96a63a22649/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/9975109/2a8351743ff2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/9975109/dbe99eef47e4/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/9975109/16317185df80/gr6.jpg

相似文献

1
Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapy.严重的造血干细胞炎症会损害慢性肉芽肿病的基因治疗。
Cell Rep Med. 2023 Feb 21;4(2):100919. doi: 10.1016/j.xcrm.2023.100919. Epub 2023 Jan 26.
2
Competitive sgRNA Screen Identifies p38 MAPK as a Druggable Target to Improve HSPC Engraftment.竞争性 sgRNA 筛选鉴定 p38 MAPK 为改善 HSPC 植入的可靶向药物。
Cells. 2020 Sep 29;9(10):2194. doi: 10.3390/cells9102194.
3
Hyperinflammation in patients with chronic granulomatous disease leads to impairment of hematopoietic stem cell functions.慢性肉芽肿病患者的过度炎症会导致造血干细胞功能受损。
J Allergy Clin Immunol. 2016 Jul;138(1):219-228.e9. doi: 10.1016/j.jaci.2015.11.028. Epub 2016 Feb 4.
4
Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis.用于X连锁慢性肉芽肿病基因治疗的双调控慢病毒载体
Mol Ther. 2014 Aug;22(8):1472-1483. doi: 10.1038/mt.2014.87. Epub 2014 May 29.
5
Lentiviral Gene Therapy of Chronic Granulomatous Disease: Functional Assessment of Universal and Tissue-Specific Promoters.慢性肉芽肿病的慢病毒基因治疗:通用启动子和组织特异性启动子的功能评估
Hum Gene Ther. 2023 Jan;34(1-2):19-29. doi: 10.1089/hum.2022.140. Epub 2022 Dec 27.
6
Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.慢性肉芽肿病:临床、分子及治疗方面
Pediatr Allergy Immunol. 2016 May;27(3):242-53. doi: 10.1111/pai.12527. Epub 2016 Jan 21.
7
CRISPR-Mediated Knockout of Cybb in NSG Mice Establishes a Model of Chronic Granulomatous Disease for Human Stem-Cell Gene Therapy Transplants.CRISPR介导的NSG小鼠Cybb基因敲除建立了用于人类干细胞基因治疗移植的慢性肉芽肿病模型。
Hum Gene Ther. 2017 Jul;28(7):565-575. doi: 10.1089/hum.2017.005. Epub 2017 Mar 6.
8
A Review of Chronic Granulomatous Disease.慢性肉芽肿病综述。
Adv Ther. 2017 Dec;34(12):2543-2557. doi: 10.1007/s12325-017-0636-2. Epub 2017 Nov 22.
9
Advances in the treatment of Chronic Granulomatous Disease by gene therapy.基因疗法治疗慢性肉芽肿病的进展。
Curr Gene Ther. 2007 Jun;7(3):155-61. doi: 10.2174/156652307780859044.
10
[A therapeutic approach towards chronic granulomatous disease].[慢性肉芽肿病的一种治疗方法]
Nihon Rinsho Meneki Gakkai Kaishi. 2014;37(6):437-46. doi: 10.2177/jsci.37.437.

引用本文的文献

1
Machine-Learning Predictive Tool for the Individualized Prediction of Outcomes of Hematopoietic Cell Transplantation for Sickle Cell Disease: Registry-Based Study.镰状细胞病造血细胞移植结局个体化预测的机器学习预测工具:基于登记处的研究
JMIR AI. 2025 Sep 15;4:e64519. doi: 10.2196/64519.
2
Application of Artificial Intelligence in Inborn Errors of Immunity Identification and Management: Past, Present, and Future-A Systematic Review.人工智能在遗传性免疫缺陷病识别与管理中的应用:过去、现在与未来——一项系统综述
J Clin Med. 2025 Aug 23;14(17):5958. doi: 10.3390/jcm14175958.
3
Severe inflammation and lineage skewing are associated with poor engraftment of engineered hematopoietic stem cells in patients with sickle cell disease.

本文引用的文献

1
Challenges in translational machine learning.转化机器学习中的挑战。
Hum Genet. 2022 Sep;141(9):1451-1466. doi: 10.1007/s00439-022-02439-8. Epub 2022 Mar 4.
2
Srebf1c preserves hematopoietic stem cell function and survival as a switch of mitochondrial metabolism.Srebf1c 通过作为线粒体代谢的开关来维持造血干细胞的功能和存活。
Stem Cell Reports. 2022 Mar 8;17(3):599-615. doi: 10.1016/j.stemcr.2022.01.011. Epub 2022 Feb 10.
3
The type I interferonopathies: 10 years on.Ⅰ型干扰素病:10 年进展。
严重炎症和谱系偏移与镰状细胞病患者中工程化造血干细胞植入不佳有关。
Nat Commun. 2025 Apr 1;16(1):3137. doi: 10.1038/s41467-025-58321-4.
4
Viral-based gene therapy clinical trials for immune deficiencies and blood disorders from 2013 until 2023 - an overview.2013年至2023年基于病毒的免疫缺陷和血液疾病基因治疗临床试验综述
Regen Ther. 2024 Dec 31;28:262-279. doi: 10.1016/j.reth.2024.12.007. eCollection 2025 Mar.
5
Non-viral DNA delivery and TALEN editing correct the sickle cell mutation in hematopoietic stem cells.非病毒 DNA 递送和 TALEN 编辑纠正造血干细胞中的镰状细胞突变。
Nat Commun. 2024 Jun 11;15(1):4965. doi: 10.1038/s41467-024-49353-3.
6
FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice.FLT3L 调控人类和小鼠部分重叠的造血谱系发育。
Cell. 2024 May 23;187(11):2817-2837.e31. doi: 10.1016/j.cell.2024.04.009. Epub 2024 May 3.
7
Myelodysplasia and transgene inactivation in X-CGD-γ retroviral gene therapy: The usual suspects and new players.X连锁慢性肉芽肿病γ逆转录病毒基因治疗中的骨髓发育异常和转基因失活:常见因素与新发现
Mol Ther. 2023 Dec 6;31(12):3367-3368. doi: 10.1016/j.ymthe.2023.11.007. Epub 2023 Nov 18.
8
Advances in gene therapy for inborn errors of immunity.免疫遗传性缺陷的基因治疗进展。
Curr Opin Allergy Clin Immunol. 2023 Dec 1;23(6):467-477. doi: 10.1097/ACI.0000000000000952. Epub 2023 Oct 13.
9
Progress in the field of hematopoietic stem cell-based therapies for inborn errors of immunity.基于造血干细胞的免疫性先天缺陷治疗领域的进展。
Curr Opin Pediatr. 2023 Dec 1;35(6):663-670. doi: 10.1097/MOP.0000000000001292. Epub 2023 Sep 21.
10
Genetically confirmed chronic granulomatous disease in a Kenyan child: case report.肯尼亚一名儿童经基因确证的慢性肉芽肿病:病例报告。
Front Immunol. 2023 May 18;14:1172848. doi: 10.3389/fimmu.2023.1172848. eCollection 2023.
Nat Rev Immunol. 2022 Aug;22(8):471-483. doi: 10.1038/s41577-021-00633-9. Epub 2021 Oct 20.
4
Transitions in lineage specification and gene regulatory networks in hematopoietic stem/progenitor cells over human development.人类发育过程中造血干/祖细胞谱系特化和基因调控网络的转变。
Cell Rep. 2021 Sep 14;36(11):109698. doi: 10.1016/j.celrep.2021.109698.
5
Gene signature extraction and cell identity recognition at the single-cell level with Cell-ID.利用 Cell-ID 在单细胞水平上进行基因特征提取和细胞身份识别。
Nat Biotechnol. 2021 Sep;39(9):1095-1102. doi: 10.1038/s41587-021-00896-6. Epub 2021 Apr 29.
6
Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells.儿童 MDS 和与骨髓衰竭相关的胚系突变 SAMD9 和 SAMD9L 会损害原代造血细胞中的多个通路。
Leukemia. 2021 Nov;35(11):3232-3244. doi: 10.1038/s41375-021-01212-6. Epub 2021 Mar 17.
7
Hematopoietic Tumors in a Mouse Model of X-linked Chronic Granulomatous Disease after Lentiviral Vector-Mediated Gene Therapy.X 连锁慢性肉芽肿病小鼠模型中经慢病毒载体介导的基因治疗后的造血肿瘤。
Mol Ther. 2021 Jan 6;29(1):86-102. doi: 10.1016/j.ymthe.2020.09.030. Epub 2020 Sep 23.
8
Competitive sgRNA Screen Identifies p38 MAPK as a Druggable Target to Improve HSPC Engraftment.竞争性 sgRNA 筛选鉴定 p38 MAPK 为改善 HSPC 植入的可靶向药物。
Cells. 2020 Sep 29;9(10):2194. doi: 10.3390/cells9102194.
9
Janus Kinase Inhibition in the Aicardi-Goutières Syndrome.JAK激酶抑制在Aicardi-Goutières综合征中的作用
N Engl J Med. 2020 Sep 3;383(10):986-989. doi: 10.1056/NEJMc2001362.
10
Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults.慢性肉芽肿病的造血细胞移植:712例儿童和成人的研究
Blood. 2020 Sep 3;136(10):1201-1211. doi: 10.1182/blood.2020005590.